Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin.
The Type 1 Diabetes Therapeutics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Type 1 Diabetes Therapeutics industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Type 1 Diabetes Therapeutics market can be split based on product types, major applications, and important countries as follows:
Key players in the global Type 1 Diabetes Therapeutics market covered in Chapter 12:
GlaxoSmithKline plc
Macrogenics, Inc.
Sanofi SA
Johnson＆Johnson
DiaVacs, Inc.
Novartis AG
Boehringer Ingelheim GmbH
Merck＆Co., Inc.
XOMA Corp.
B.Braun Melsungen AG
Takeda Pharmaceutical Company Limited
Biodel, Inc.
Novo Nordisk
AstraZeneca plc
Eli Lilly and Company
In Chapter 4 and 14.1, on the basis of types, the Type 1 Diabetes Therapeutics market from 2015 to 2025 is primarily split into:
Rapid acting insulin analogs
Long acting insulin analogs
Premix insulin analogs
In Chapter 5 and 14.2, on the basis of applications, the Type 1 Diabetes Therapeutics market from 2015 to 2025 covers:
Patient
Hospital
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Type 1 Diabetes Therapeutics Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Type 1 Diabetes Therapeutics
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Type 1 Diabetes Therapeutics industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Type 1 Diabetes Therapeutics Market Size, 2015 – 2020
2.1.2 Global Type 1 Diabetes Therapeutics Market Size by Type, 2015 – 2020
2.1.3 Global Type 1 Diabetes Therapeutics Market Size by Application, 2015 – 2020
2.1.4 Global Type 1 Diabetes Therapeutics Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Type 1 Diabetes Therapeutics Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Type 1 Diabetes Therapeutics Analysis
3.2 Major Players of Type 1 Diabetes Therapeutics
3.3 Type 1 Diabetes Therapeutics Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Type 1 Diabetes Therapeutics
3.3.3 Labor Cost of Type 1 Diabetes Therapeutics
3.4 Market Distributors of Type 1 Diabetes Therapeutics
3.5 Major Downstream Buyers of Type 1 Diabetes Therapeutics Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Type 1 Diabetes Therapeutics Market, by Type
4.1 Global Type 1 Diabetes Therapeutics Value and Market Share by Type (2015-2020)
4.2 Global Type 1 Diabetes Therapeutics Production and Market Share by Type (2015-2020)
4.3 Global Type 1 Diabetes Therapeutics Value and Growth Rate by Type (2015-2020)
4.3.1 Global Type 1 Diabetes Therapeutics Value and Growth Rate of Rapid acting insulin analogs
4.3.2 Global Type 1 Diabetes Therapeutics Value and Growth Rate of Long acting insulin analogs
4.3.3 Global Type 1 Diabetes Therapeutics Value and Growth Rate of Premix insulin analogs
4.4 Global Type 1 Diabetes Therapeutics Price Analysis by Type (2015-2020)
5 Type 1 Diabetes Therapeutics Market, by Application
5.1 Downstream Market Overview
5.2 Global Type 1 Diabetes Therapeutics Consumption and Market Share by Application (2015-2020)
5.3 Global Type 1 Diabetes Therapeutics Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Patient (2015-2020)
5.3.2 Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Hospital (2015-2020)
5.3.3 Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Others (2015-2020)
6 Global Type 1 Diabetes Therapeutics Market Analysis by Regions
6.1 Global Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Regions
6.1.1 Global Type 1 Diabetes Therapeutics Sales by Regions (2015-2020)
6.1.2 Global Type 1 Diabetes Therapeutics Revenue by Regions (2015-2020)
6.2 North America Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
6.3 Europe Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
6.6 South America Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
7 North America Type 1 Diabetes Therapeutics Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Countries
7.2.1 North America Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
7.2.2 North America Type 1 Diabetes Therapeutics Revenue by Countries (2015-2020)
7.3 United States Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
7.4 Canada Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
7.5 Mexico Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8 Europe Type 1 Diabetes Therapeutics Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Countries
8.2.1 Europe Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
8.2.2 Europe Type 1 Diabetes Therapeutics Revenue by Countries (2015-2020)
8.3 Germany Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8.4 UK Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8.5 France Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8.6 Italy Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8.7 Spain Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
8.8 Russia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9 Asia Pacific Type 1 Diabetes Therapeutics Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
9.2.2 Asia Pacific Type 1 Diabetes Therapeutics Revenue by Countries (2015-2020)
9.3 China Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9.4 Japan Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Korea Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9.6 India Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
9.8 Australia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
10 Middle East and Africa Type 1 Diabetes Therapeutics Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Type 1 Diabetes Therapeutics Revenue by Countries (2015-2020)
10.3 Saudi Arabia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
10.4 UAE Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
10.5 Egypt Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
10.6 Nigeria Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
10.7 South Africa Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
11 South America Type 1 Diabetes Therapeutics Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Type 1 Diabetes Therapeutics Sales, Revenue and Market Share by Countries
11.2.1 South America Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
11.2.2 South America Type 1 Diabetes Therapeutics Revenue by Countries (2015-2020)
11.3 Brazil Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
11.4 Argentina Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
11.5 Columbia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
11.6 Chile Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 GlaxoSmithKline plc
12.1.1 GlaxoSmithKline plc Basic Information
12.1.2 Type 1 Diabetes Therapeutics Product Introduction
12.1.3 GlaxoSmithKline plc Production, Value, Price, Gross Margin 2015-2020
12.2 Macrogenics, Inc.
12.2.1 Macrogenics, Inc. Basic Information
12.2.2 Type 1 Diabetes Therapeutics Product Introduction
12.2.3 Macrogenics, Inc. Production, Value, Price, Gross Margin 2015-2020
12.3 Sanofi SA
12.3.1 Sanofi SA Basic Information
12.3.2 Type 1 Diabetes Therapeutics Product Introduction
12.3.3 Sanofi SA Production, Value, Price, Gross Margin 2015-2020
12.4 Johnson＆Johnson
12.4.1 Johnson＆Johnson Basic Information
12.4.2 Type 1 Diabetes Therapeutics Product Introduction
12.4.3 Johnson＆Johnson Production, Value, Price, Gross Margin 2015-2020
12.5 DiaVacs, Inc.
12.5.1 DiaVacs, Inc. Basic Information
12.5.2 Type 1 Diabetes Therapeutics Product Introduction
12.5.3 DiaVacs, Inc. Production, Value, Price, Gross Margin 2015-2020
12.6 Novartis AG
12.6.1 Novartis AG Basic Information
12.6.2 Type 1 Diabetes Therapeutics Product Introduction
12.6.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Basic Information
12.7.2 Type 1 Diabetes Therapeutics Product Introduction
12.7.3 Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2015-2020
12.8 Merck＆Co., Inc.
12.8.1 Merck＆Co., Inc. Basic Information
12.8.2 Type 1 Diabetes Therapeutics Product Introduction
12.8.3 Merck＆Co., Inc. Production, Value, Price, Gross Margin 2015-2020
12.9 XOMA Corp.
12.9.1 XOMA Corp. Basic Information
12.9.2 Type 1 Diabetes Therapeutics Product Introduction
12.9.3 XOMA Corp. Production, Value, Price, Gross Margin 2015-2020
12.10 B.Braun Melsungen AG
12.10.1 B.Braun Melsungen AG Basic Information
12.10.2 Type 1 Diabetes Therapeutics Product Introduction
12.10.3 B.Braun Melsungen AG Production, Value, Price, Gross Margin 2015-2020
12.11 Takeda Pharmaceutical Company Limited
12.11.1 Takeda Pharmaceutical Company Limited Basic Information
12.11.2 Type 1 Diabetes Therapeutics Product Introduction
12.11.3 Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2015-2020
12.12 Biodel, Inc.
12.12.1 Biodel, Inc. Basic Information
12.12.2 Type 1 Diabetes Therapeutics Product Introduction
12.12.3 Biodel, Inc. Production, Value, Price, Gross Margin 2015-2020
12.13 Novo Nordisk
12.13.1 Novo Nordisk Basic Information
12.13.2 Type 1 Diabetes Therapeutics Product Introduction
12.13.3 Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
12.14 AstraZeneca plc
12.14.1 AstraZeneca plc Basic Information
12.14.2 Type 1 Diabetes Therapeutics Product Introduction
12.14.3 AstraZeneca plc Production, Value, Price, Gross Margin 2015-2020
12.15 Eli Lilly and Company
12.15.1 Eli Lilly and Company Basic Information
12.15.2 Type 1 Diabetes Therapeutics Product Introduction
12.15.3 Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Type 1 Diabetes Therapeutics Market Forecast
14.1 Global Type 1 Diabetes Therapeutics Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Rapid acting insulin analogs Market Value and Volume Forecast (2020-2025)
14.1.2 Long acting insulin analogs Market Value and Volume Forecast (2020-2025)
14.1.3 Premix insulin analogs Market Value and Volume Forecast (2020-2025)
14.2 Global Type 1 Diabetes Therapeutics Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Patient Market Value and Volume Forecast (2020-2025)
14.2.2 Hospital Market Value and Volume Forecast (2020-2025)
14.2.3 Others Market Value and Volume Forecast (2020-2025)
14.3 Type 1 Diabetes Therapeutics Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Type 1 Diabetes Therapeutics
Table Product Specification of Type 1 Diabetes Therapeutics
Table Type 1 Diabetes Therapeutics Key Market Segments
Table Key Players Type 1 Diabetes Therapeutics Covered
Figure Global Type 1 Diabetes Therapeutics Market Size, 2015 – 2025
Table Different Types of Type 1 Diabetes Therapeutics
Figure Global Type 1 Diabetes Therapeutics Value ($) Segment by Type from 2015-2020
Figure Global Type 1 Diabetes Therapeutics Market Share by Types in 2019
Table Different Applications of Type 1 Diabetes Therapeutics
Figure Global Type 1 Diabetes Therapeutics Value ($) Segment by Applications from 2015-2020
Figure Global Type 1 Diabetes Therapeutics Market Share by Applications in 2019
Figure Global Type 1 Diabetes Therapeutics Market Share by Regions in 2019
Figure North America Type 1 Diabetes Therapeutics Production Value ($) and Growth Rate (2015-2020)
Figure Europe Type 1 Diabetes Therapeutics Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Type 1 Diabetes Therapeutics Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Type 1 Diabetes Therapeutics Production Value ($) and Growth Rate (2015-2020)
Figure South America Type 1 Diabetes Therapeutics Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Type 1 Diabetes Therapeutics
Table Upstream Raw Material Suppliers of Type 1 Diabetes Therapeutics with Contact Information
Table Major Players Headquarters, and Service Area of Type 1 Diabetes Therapeutics
Figure Major Players Production Value Market Share of Type 1 Diabetes Therapeutics in 2019
Table Major Players Type 1 Diabetes Therapeutics Product Types in 2019
Figure Production Process of Type 1 Diabetes Therapeutics
Figure Manufacturing Cost Structure of Type 1 Diabetes Therapeutics
Figure Channel Status of Type 1 Diabetes Therapeutics
Table Major Distributors of Type 1 Diabetes Therapeutics with Contact Information
Table Major Downstream Buyers of Type 1 Diabetes Therapeutics with Contact Information
Table Global Type 1 Diabetes Therapeutics Value ($) by Type (2015-2020)
Table Global Type 1 Diabetes Therapeutics Value Share by Type (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Value Share by Type (2015-2020)
Table Global Type 1 Diabetes Therapeutics Production by Type (2015-2020)
Table Global Type 1 Diabetes Therapeutics Production Share by Type (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Production Share by Type (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Value ($) and Growth Rate of Rapid acting insulin analogs (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Value ($) and Growth Rate of Long acting insulin analogs (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Value ($) and Growth Rate of Premix insulin analogs (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Type 1 Diabetes Therapeutics Consumption by Application (2015-2020)
Table Global Type 1 Diabetes Therapeutics Consumption Market Share by Application (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Consumption Market Share by Application (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Patient (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Hospital (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Consumption and Growth Rate of Others (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Global Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table Global Type 1 Diabetes Therapeutics Sales by Regions (2015-2020)
Table Global Type 1 Diabetes Therapeutics Sales Market Share by Regions (2015-2020)
Table Global Type 1 Diabetes Therapeutics Revenue (M USD) by Regions (2015-2020)
Table Global Type 1 Diabetes Therapeutics Revenue Market Share by Regions (2015-2020)
Table Global Type 1 Diabetes Therapeutics Revenue Market Share by Regions in 2015
Table Global Type 1 Diabetes Therapeutics Revenue Market Share by Regions in 2019
Figure North America Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Europe Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure South America Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table North America Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
Table North America Type 1 Diabetes Therapeutics Sales Market Share by Countries (2015-2020)
Table North America Type 1 Diabetes Therapeutics Revenue (M USD) by Countries (2015-2020)
Table North America Type 1 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020)
Figure United States Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Canada Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Mexico Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table Europe Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
Table Europe Type 1 Diabetes Therapeutics Sales Market Share by Countries (2015-2020)
Table Europe Type 1 Diabetes Therapeutics Revenue (M USD) by Countries (2015-2020)
Table Europe Type 1 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Germany Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure UK Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure France Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Italy Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Spain Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Russia Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
Table Asia Pacific Type 1 Diabetes Therapeutics Sales Market Share by Countries (2015-2020)
Table Asia Pacific Type 1 Diabetes Therapeutics Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Type 1 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020)
Figure China Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Japan Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure South Korea Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure India Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Southeast Asia Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Australia Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Middle East Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table Middle East Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
Table Middle East and Africa Type 1 Diabetes Therapeutics Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Type 1 Diabetes Therapeutics Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Type 1 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure UAE Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Egypt Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Nigeria Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure South Africa Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure South America Type 1 Diabetes Therapeutics Revenue (M USD) and Growth (2015-2020)
Table South America Type 1 Diabetes Therapeutics Sales by Countries (2015-2020)
Table South America Type 1 Diabetes Therapeutics Sales Market Share by Countries (2015-2020)
Table South America Type 1 Diabetes Therapeutics Revenue (M USD) by Countries (2015-2020)
Table South America Type 1 Diabetes Therapeutics Revenue Market Share by Countries (2015-2020)
Figure Brazil Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Argentina Type 1 Diabetes Therapeutics Sales and Growth Rate (2015-2020)
Figure Columbia Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Chile Type 1 Diabetes Therapeutics Sales and Growth (2015-2020)
Figure Top 3 Market Share of Type 1 Diabetes Therapeutics Companies in 2019
Figure Top 6 Market Share of Type 1 Diabetes Therapeutics Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Product Introduction
Figure GlaxoSmithKline plc Production and Growth Rate
Figure GlaxoSmithKline plc Value ($) Market Share 2015-2020
Table Macrogenics, Inc. Profile
Table Macrogenics, Inc. Product Introduction
Figure Macrogenics, Inc. Production and Growth Rate
Figure Macrogenics, Inc. Value ($) Market Share 2015-2020
Table Sanofi SA Profile
Table Sanofi SA Product Introduction
Figure Sanofi SA Production and Growth Rate
Figure Sanofi SA Value ($) Market Share 2015-2020
Table Johnson＆Johnson Profile
Table Johnson＆Johnson Product Introduction
Figure Johnson＆Johnson Production and Growth Rate
Figure Johnson＆Johnson Value ($) Market Share 2015-2020
Table DiaVacs, Inc. Profile
Table DiaVacs, Inc. Product Introduction
Figure DiaVacs, Inc. Production and Growth Rate
Figure DiaVacs, Inc. Value ($) Market Share 2015-2020
Table Novartis AG Profile
Table Novartis AG Product Introduction
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Product Introduction
Figure Boehringer Ingelheim GmbH Production and Growth Rate
Figure Boehringer Ingelheim GmbH Value ($) Market Share 2015-2020
Table Merck＆Co., Inc. Profile
Table Merck＆Co., Inc. Product Introduction
Figure Merck＆Co., Inc. Production and Growth Rate
Figure Merck＆Co., Inc. Value ($) Market Share 2015-2020
Table XOMA Corp. Profile
Table XOMA Corp. Product Introduction
Figure XOMA Corp. Production and Growth Rate
Figure XOMA Corp. Value ($) Market Share 2015-2020
Table B.Braun Melsungen AG Profile
Table B.Braun Melsungen AG Product Introduction
Figure B.Braun Melsungen AG Production and Growth Rate
Figure B.Braun Melsungen AG Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Product Introduction
Figure Takeda Pharmaceutical Company Limited Production and Growth Rate
Figure Takeda Pharmaceutical Company Limited Value ($) Market Share 2015-2020
Table Biodel, Inc. Profile
Table Biodel, Inc. Product Introduction
Figure Biodel, Inc. Production and Growth Rate
Figure Biodel, Inc. Value ($) Market Share 2015-2020
Table Novo Nordisk Profile
Table Novo Nordisk Product Introduction
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Table AstraZeneca plc Profile
Table AstraZeneca plc Product Introduction
Figure AstraZeneca plc Production and Growth Rate
Figure AstraZeneca plc Value ($) Market Share 2015-2020
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Product Introduction
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Market Driving Factors of Type 1 Diabetes Therapeutics
Table Merger, Acquisition and New Investment
Table Global Type 1 Diabetes Therapeutics Market Value ($) Forecast, by Type
Table Global Type 1 Diabetes Therapeutics Market Volume Forecast, by Type
Figure Global Type 1 Diabetes Therapeutics Market Value ($) and Growth Rate Forecast of Rapid acting insulin analogs (2020-2025)
Figure Global Type 1 Diabetes Therapeutics Market Volume ($) and Growth Rate Forecast of Rapid acting insulin analogs (2020-2025)
Figure Global Type 1 Diabetes Therapeutics Market Value ($) and Growth Rate Forecast of Long acting insulin analogs (2020-2025)
Figure Global Type 1 Diabetes Therapeutics Market Volume ($) and Growth Rate Forecast of Long acting insulin analogs (2020-2025)
Figure Global Type 1 Diabetes Therapeutics Market Value ($) and Growth Rate Forecast of Premix insulin analogs (2020-2025)
Figure Global Type 1 Diabetes Therapeutics Market Volume ($) and Growth Rate Forecast of Premix insulin analogs (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Patient (2020-2025)
Figure Market Volume and Growth Rate Forecast of Patient (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Research Methodology:
Type 1 Diabetes Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|